ArticleJournal of nanobiotechnology2026
Anti-NRP1 peptide-engineered ROS/pH dual-responsive nanoparticles for Alpelisib delivery regulate Sema3A-NRP1/PI3K-AKT signaling to balance oxidative stress and inhibit angiogenesis in endometriosis.
Jie Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.